Biodesix partners with Vanderbilt to develop an AI-powered lung nodule risk test, with RSNA data due December 2026 and ...

Brent crude falls 2.08% to $107.57 as Trump waives Russia sanctions, while WTI drops to $99.46 amid continuing Middle East ...

OpenWorld signs a Blocksight merger agreement to support proposed tokenized financing programs of up to $1.13 billion with ...

Oculis completes randomization of 176 patients in its PREDICT-1 Licaminlimab dry eye trial, with topline results expected ...

Fifth Third Bancorp reports $828 million in Q3 2026 net income, $1.13 adjusted EPS and $1.01 billion in noninterest income ...

Transocean adds $550 million in U.S. Gulf drilling backlog through Deepwater Proteus and Deepwater Conqueror contracts ...

Cleveland-Cliffs reports $612 million in Q3 2026 adjusted EBITDA, $5.6 billion revenue and forecasts over $4 billion in ...

IDEAYA reports 57% eye preservation in its darovasertib OptimUM-09 trial and 7.4 months median progression-free survival in ...

Takeda reports 67% lower relative ulcerative colitis complication risk with an ENTYVIO disease-clearance treatment strategy ...

Eli Lilly reports 50% clinical remission among pediatric Omvoh responders at Week 52 in its Phase 3 SHINE-2 ulcerative ...

Red Cat Holdings proposes acquiring Steyr Motors for €39 per share, a 28.9% premium, with shareholder acceptance expected to ...

AbbVie reports 40.5% endoscopic remission with ABBV-466 at Week 24 in its Phase 2a Crohn's disease trial, compared with 22.4% ...